These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 31978322)
21. [Transport proteins as drug targets in Plasmodium falciparum. New perspectives in the treatment of malaria]. Ellekvist P; Colding H Ugeskr Laeger; 2006 Mar; 168(13):1314-7. PubMed ID: 16579884 [TBL] [Abstract][Full Text] [Related]
22. Plasmodium falciparum: new molecular targets with potential for antimalarial drug development. Gardiner DL; Skinner-Adams TS; Brown CL; Andrews KT; Stack CM; McCarthy JS; Dalton JP; Trenholme KR Expert Rev Anti Infect Ther; 2009 Nov; 7(9):1087-98. PubMed ID: 19883329 [TBL] [Abstract][Full Text] [Related]
23. Natural product-inspired aryl isonitriles as a new class of antimalarial compounds against drug-resistant parasites. Kyei-Baffour K; Davis DC; Boskovic Z; Kato N; Dai M Bioorg Med Chem; 2020 Oct; 28(19):115678. PubMed ID: 32912433 [TBL] [Abstract][Full Text] [Related]
24. Identification via a Parallel Hit Progression Strategy of Improved Small Molecule Inhibitors of the Malaria Purine Uptake Transporter that Inhibit Sosa Y; Deniskin R; Frame IJ; Steiginga MS; Bandyopadhyay D; Graybill TL; Kallal LA; Ouellette MT; Pope AJ; Widdowson KL; Young RJ; Akabas MH ACS Infect Dis; 2019 Oct; 5(10):1738-1753. PubMed ID: 31373203 [TBL] [Abstract][Full Text] [Related]
25. Antimalarial drug targets and drugs targeting dolichol metabolic pathway of Plasmodium falciparum. Qidwai T; Priya A; Khan NA; Tripathi H; Khan F; Darokar MP; Pal A; Bawankule DU; Shukla RK; Bhakuni RS Curr Drug Targets; 2014 Apr; 15(4):374-409. PubMed ID: 23848395 [TBL] [Abstract][Full Text] [Related]
26. Plasmodium chloroquine resistance and the search for a replacement antimalarial drug. Wellems TE Science; 2002 Oct; 298(5591):124-6. PubMed ID: 12364789 [TBL] [Abstract][Full Text] [Related]
27. [The current status of the resistance of malaria pathogens to antimalarials]. Kondrashin AV; Baranova AM; Morozov EN; Morozova LF; Stepanova EV Med Parazitol (Mosk); 2014; (3):51-7. PubMed ID: 25286554 [TBL] [Abstract][Full Text] [Related]
29. Helicases - feasible antimalarial drug target for Plasmodium falciparum. Tuteja R FEBS J; 2007 Sep; 274(18):4699-704. PubMed ID: 17824956 [TBL] [Abstract][Full Text] [Related]
30. Identification of Antimalarial Compounds That Require CLAG3 for Their Uptake by Mira-Martínez S; Pickford AK; Rovira-Graells N; Guetens P; Tintó-Font E; Cortés A; Rosanas-Urgell A Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782998 [TBL] [Abstract][Full Text] [Related]
31. A brief history of artemisinin: Modes of action and mechanisms of resistance. Lu F; He XL; Richard C; Cao J Chin J Nat Med; 2019 May; 17(5):331-336. PubMed ID: 31171267 [TBL] [Abstract][Full Text] [Related]
32. Functional annotation of serine hydrolases in the asexual erythrocytic stage of Plasmodium falciparum. Elahi R; Ray WK; Dapper C; Dalal S; Helm RF; Klemba M Sci Rep; 2019 Nov; 9(1):17532. PubMed ID: 31772212 [TBL] [Abstract][Full Text] [Related]
33. Plasmepsins IX and X are essential and druggable mediators of malaria parasite egress and invasion. Nasamu AS; Glushakova S; Russo I; Vaupel B; Oksman A; Kim AS; Fremont DH; Tolia N; Beck JR; Meyers MJ; Niles JC; Zimmerberg J; Goldberg DE Science; 2017 Oct; 358(6362):518-522. PubMed ID: 29074774 [TBL] [Abstract][Full Text] [Related]
34. Elucidating Mechanisms of Drug-Resistant Plasmodium falciparum. Ross LS; Fidock DA Cell Host Microbe; 2019 Jul; 26(1):35-47. PubMed ID: 31295423 [TBL] [Abstract][Full Text] [Related]
35. KBE009: An antimalarial bestatin-like inhibitor of the Plasmodium falciparum M1 aminopeptidase discovered in an Ugi multicomponent reaction-derived peptidomimetic library. González-Bacerio J; Maluf SEC; Méndez Y; Pascual I; Florent I; Melo PMS; Budu A; Ferreira JC; Moreno E; Carmona AK; Rivera DG; Alonso Del Rivero M; Gazarini ML Bioorg Med Chem; 2017 Sep; 25(17):4628-4636. PubMed ID: 28728898 [TBL] [Abstract][Full Text] [Related]
36. The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs. Herman JD; Pepper LR; Cortese JF; Estiu G; Galinsky K; Zuzarte-Luis V; Derbyshire ER; Ribacke U; Lukens AK; Santos SA; Patel V; Clish CB; Sullivan WJ; Zhou H; Bopp SE; Schimmel P; Lindquist S; Clardy J; Mota MM; Keller TL; Whitman M; Wiest O; Wirth DF; Mazitschek R Sci Transl Med; 2015 May; 7(288):288ra77. PubMed ID: 25995223 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of efflux of quinolines as new therapeutic strategy in malaria. Henry M; Alibert S; Rogier C; Barbe J; Pradines B Curr Top Med Chem; 2008; 8(7):563-78. PubMed ID: 18473883 [TBL] [Abstract][Full Text] [Related]
38. 3,5-bis(benzylidene)-4-piperidones and related N-acyl analogs: a novel cluster of antimalarials targeting the liver stage of Plasmodium falciparum. Das U; Singh RS; Alcorn J; Hickman MR; Sciotti RJ; Leed SE; Lee PJ; Roncal N; Dimmock JR Bioorg Med Chem; 2013 Dec; 21(23):7250-6. PubMed ID: 24139941 [TBL] [Abstract][Full Text] [Related]